CSL has more upside..., page-343

That's the point. it is trading on 70x and there is a world wide correction. expect it to trade at 30x again.

What happens if there expansion in to China causes a $1bn hole? That is 8% of earnings and 50% of NPAT. I'm not an analyst but those are the numbers that were talking in China.

As I posted the other day

The Melbourne-headquartered group - a global leader in treatments for immunodeficiency and bleeding diseases such as hemophilia, and also one of the world's biggest suppliers of flu vaccines - said its 2020 guidance included a headwind from moving to a direct distribution model in China, which would dent sales by $US340 million to $US370 million.

But chief executive Paul Perreault said that short-term pain was worth it, as the new model would enable further expansion into China, which accounted for $625 million of its revenue last year out of $8.53 billion in global sales.

disallowed/business/companies/csl-gets-investors-blood-moving-with-outlook-for-growth-20190813-p52grh.html

for more information https://www.csl.com/contact/worldwide-locations

Ruide
R&D and Manufacturing
phone: +8627 86698337
fax: +8627 83923470
No. 99 of Guanggu Seventh Rd
Donghu New Technology Development Zone
Wuhan City,
Hubei Province 430206